Literature DB >> 19035409

Role of psychiatric comorbidity in chronic Lyme disease.

Afton L Hassett1, Diane C Radvanski, Steven Buyske, Shantal V Savage, Michael Gara, Javier I Escobar, Leonard H Sigal.   

Abstract

OBJECTIVE: To evaluate the prevalence and role of psychiatric comorbidity and other psychological factors in patients with chronic Lyme disease (CLD).
METHODS: We assessed 159 patients drawn from a cohort of 240 patients evaluated at an academic Lyme disease referral center. Patients were screened for common axis I psychiatric disorders (e.g., depressive and anxiety disorders); structured clinical interviews confirmed diagnoses. Axis II personality disorders, functional status, and traits like negative and positive affect and pain catastrophizing were also evaluated. A physician blind to psychiatric assessment results performed a medical evaluation. Two groups of CLD patients (those with post-Lyme disease syndrome and those with medically unexplained symptoms attributed to Lyme disease but without Borrelia burgdorferi infection) were compared with 2 groups of patients without CLD (patients recovered from Lyme disease and those with an identifiable medical condition explaining symptoms attributed to Lyme disease).
RESULTS: After adjusting for age and sex, axis I psychiatric disorders were more common in CLD patients than in comparison patients (P = 0.02, odds ratio 2.64, 95% confidence interval 1.30-5.35), but personality disorders were not. Patients with CLD had higher negative affect, lower positive affect, and a greater tendency to catastrophize pain (P < 0.001) than comparison patients. All psychological factors except personality disorders were related to level of functioning. A predictive model based on these psychological variables was confirmed. Fibromyalgia was diagnosed in 46.8% of CLD patients.
CONCLUSION: Psychiatric comorbidity and other psychological factors distinguished CLD patients from other patients commonly seen in Lyme disease referral centers, and were related to poor functional outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 19035409     DOI: 10.1002/art.24314

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

2.  Antiscience and ethical concerns associated with advocacy of Lyme disease.

Authors:  Paul G Auwaerter; Johan S Bakken; Raymond J Dattwyler; J Stephen Dumler; John J Halperin; Edward McSweegan; Robert B Nadelman; Susan O'Connell; Eugene D Shapiro; Sunil K Sood; Allen C Steere; Arthur Weinstein; Gary P Wormser
Journal:  Lancet Infect Dis       Date:  2011-09       Impact factor: 25.071

3.  Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions.

Authors:  Siwen Wang; Luwei Quan; Jorge E Chavarro; Natalie Slopen; Laura D Kubzansky; Karestan C Koenen; Jae Hee Kang; Marc G Weisskopf; Westyn Branch-Elliman; Andrea L Roberts
Journal:  JAMA Psychiatry       Date:  2022-09-07       Impact factor: 25.911

Review 4.  Treatment trials for post-Lyme disease symptoms revisited.

Authors:  Mark S Klempner; Phillip J Baker; Eugene D Shapiro; Adriana Marques; Raymond J Dattwyler; John J Halperin; Gary P Wormser
Journal:  Am J Med       Date:  2013-06-10       Impact factor: 4.965

5.  Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups.

Authors:  Shreya Doshi; John G Keilp; Barbara Strobino; Martin McElhiney; Judith Rabkin; Brian A Fallon
Journal:  Psychosomatics       Date:  2018-03-01       Impact factor: 2.386

6.  Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy.

Authors:  Avinash M Chandra; John G Keilp; Brian A Fallon
Journal:  Psychosomatics       Date:  2013-07-09       Impact factor: 2.386

7.  Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Authors:  John N Aucott; Alison W Rebman; Lauren A Crowder; Kathleen B Kortte
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

8.  Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health.

Authors:  H I Huppertz; P Bartmann; U Heininger; V Fingerle; M Kinet; R Klein; G C Korenke; H J Nentwich
Journal:  Eur J Pediatr       Date:  2012-07-11       Impact factor: 3.183

9.  New-onset panic, depression with suicidal thoughts, and somatic symptoms in a patient with a history of lyme disease.

Authors:  Amir Garakani; Andrew G Mitton
Journal:  Case Rep Psychiatry       Date:  2015-04-01

10.  Chronic or late lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis.

Authors:  Judith Miklossy
Journal:  Open Neurol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.